Invikafusp alfa demonstrated significant antitumor activity in TMB-H and MSI-H tumors resistant to immune checkpoint blockade, with ORRs ranging from 20.5% to 33.3%. The trial's safety profile was ...

I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

Protest at Kannadi Higher Secondary School in Palakkad in Kerala ends after suspension of teacher and headmistress over student's death.

A major automaker has announced a revolutionary trial that could give drivers more confidence in making the jump to electric ...

The UAE minister highlighted six major global health threats that change from year to year but represent the most pressing ...

EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, ...